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Transcription of the c-fos proto-oncogene is rapidly induced by serum growth factors. A short c-fos DNA 
element, the serum response element (SRE), is required for this response to serum. However, serum activates a 
series of distinct intracellular signaling pathways, and it is not known to which of these pathways the SRE 
responds. To address this question, mutations have been introduced into the SRE of an otherwise intact c-fos 
promoter/enhancer. These mutations strongly reduce the binding of a nuclear factor to this site. Plasmids 
carrying either a wild-type or mutant c-fos SRE were transfected into fibroblasts and tested for their response to 
whole serum, purified recombinant c-sis protein, the protein kinase C activator phorbol myristate acetate, and 
activators of the cyclic AMP (cAMP) second messenger system. Assays were carried out under normal 
conditions and after chronic phorbol ester-treatment to deplete phorbol ester activatable protein kinase C 
activity from transfected cells. The results show that the SRE is necessary and sufficient for response to both 
protein kinase C--dependent and-independent intracellular signaling pathways but not for response to the 
cAMP pathway. 
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Cellular growth and differentiation are largely coordi- 
nated by extracellular signals. Many such signals, in the 
form of polypeptide growth factors, act through high-af- 
finity cell-surface receptors which, in turn, activate ava- 
riety of distinct signaling pathways within the target 
cell (for a review pertinent o fibroblast mitogens, see 
Rozengurt 1986). Some of these signals reach the nu- 
cleus where they lead to changes in the pattern of cel- 
lular gene expression. One of the earliest nuclear re- 
sponses to such signals is transcriptional ctivation of 
the c-los proto-oncogene [Greenberg et al. 1984; Kruijer 
et al. 1984; Muller et al. 1984). c-fos induction is a pri- 
mary response to intracellular events triggered by 
growth factor-receptor interactions. It occurs within 
minutes and without a requirement for new protein syn- 
thesis (Greenberg et al. 1986). Induction of c-los tran- 
scription can be triggered by several distinct second 
messenger systems, including protein kinase C, free cal- 
cium, cyclic nucleotides, and other uncharacterized 
pathways (for review, see Curran 1988). Whether these 
signals reach the c-fos gene through independent or con- 
vergent routes is not known. 
One DNA sequence lement in the c-fos gene plays a 
major role in the response of the gene to extracellular 
signals. Termed the serum response lement (SRE), this 
20-bp region of hyphenated dyad symmetry located 300 
bp upstream of the c-fos cap site is both necessary and 
sufficient for the response of c-fos to whole serum in fi- 
broblasts (Treisman 1985, 1986; Gilman et al. 1986; 
Greenberg et al. 1987). Deletion of the SRE abolishes in- 
duction by serum, whereas an oligonucleotide carrying a
single copy of the sequence is sufficient o restore serum 
responsiveness to a deleted c-fos promoter. This se- 
quence is a binding site for a protein factor found in nu- 
clear extracts of a variety of cell types (Gilman et al. 
1986; Prywes and Roeder 1986; Treisman 1986; Green- 
berg et al. 1987). Mutations in the SRE that affect the 
binding of this protein also affect the biological activity 
of the element (Greenberg et al. 1987; Treisman 1987). 
HeLa cell proteins that bind to the SRE have recently 
been purified (Prywes and Roeder 1987; Schroter et al. 
1987; Treisman 1987). Such proteins are potentially re- 
cipients of incoming signals that activate c-fos tran- 
scription. 
Although the SRE is critical for the response of the 
c-fos gene to serum, it is not yet clear to which intracel- 
lular signals it responds. Serum is a complex mixture of 
growth factors and hormones, each of which may acti- 
vate multiple second messengers. To determine which 
intracellular signaling pathways use the SRE and which 
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use other sequence lements in the c-fos gene, point 
mutations have been introduced into he SRE and the 
resulting mutants have been tested for response to a set 
of purified growth factors and intracellular second mes- 
sengers. The results suggest hat in fibroblasts, at least 
three distinguishable intracellular signaling pathways 
reach the c-fos gene. Two pathways act through the SRE, 
whereas a third is completely independent of this ele- 
ment. 
Results 
Point mutations in the SRE abolish factor binding in 
vitro 
The strategy used to evaluate the role of the SRE in the 
response of the c-fos gene to various stimuli was to inac- 
tivate the element in an otherwise intact mouse c-fos 
promoter-enhancer r gion and to test the resulting mu- 
tant for response to appropriate stimuli in mouse fibro- 
blasts. Previous studies have identified critical nucleo- 
tides in the SRE required for binding of a nuclear protein 
that is presumed to mediate its activity (Gilman et al. 
1986; Treisman 1986). These contact residues are two 
pairs of adjacent guanosines that are situated symmet- 
rically within the SRE. Using site-directed mutagenesis, 
all four guanosines were mutated to cytosines (pml2 
mutations; Fig. 1A), preserving the dyad symmetry of 
the element. Wild-type and mutant c-fos sequences from 
-356 to + 109 were fused to the bacterial gene encoding 
chloramphenicol acetyltransferase (CAT). By using fu- 
sion genes, transcripts of the transfected gene could be 
distinguished easily from transcripts of the endogenous 
mouse c-fos gene in the transfected cultures. 
The mutant SRE was first tested for its ability to bind 
the nuclear SRE-binding factor present in WEHI 231 
cells (Gilman et al. 1986). Figure 2 shows a mobility- 
shift assay performed with a labeled c-fos DNA fragment 
(-356 to -274) carrying awild-type SRE. Lane 2 shows 
the specific complex formed on this fragment in WEHI 
231 nuclear extracts. When increasing amounts of an 
unlabeled purified c-fos restriction fragment (-356 to 
+ 109} also carrying a wild-type SRE were added to the 
binding reaction, binding to the wild-type probe was re- 
duced as factor was diverted to the unlabeled competitor 
fragment (lanes 3-6). When a similar competitor frag- 
ment carrying the pml2 mutations in the SRE was 
added to the reaction, binding to the probe was unaf- 
fected at up to 100-fold molar excess of competitor 
(lanes 7-10). Thus, the pml2 mutant SRE binds this 
protein in vitro with at least two orders of magnitude 
lower affinity than does the wild-type site. 
Effect of SRE point mutations on c-fos induction in vivo 
c- los-CAT fusion genes carrying either a wild-type or a 
pml2 mutant SRE were tested for their response to sev- 
eral types of stimuli. Plasmids carrying the fusion genes 
were transfected into BALB/c 3T3 cells, together with a 
plasmid carrying the human ~-globin gene; the latter 
plasmid served as an internal control for transfection el- 
ficiency. After transfection, the cells were incubated in 
medium containing 0.5% calf serum for approximately 
48 hr and then fed with either serum-flee medium (NA 
in Figs. 3-6} or serum-free medium containing the fol- 
lowing additions: 10% calf serum (CS); 40 ng/ml recom- 
binant c-sis protein (SIS), a purified polypeptide growth 
factor that acts indistinguishably from authentic 
platelet-derived growth factor (PDGF); 50 ng/ml phorbol 
myristate acetate (PMA), an activator of protein kinase 
C (pkC); 0.5 mM isobutylmethylxanthine (IBMX), a 
phosphodiesterase inhibitor, and 10 ~ZM forskolin, an ac- 
tivator of adenylate cyclase (IF). After an additional 45- 
rain incubation, the cells were harvested, and total cyto- 
plasmic RNA was prepared. 
RNA was assayed by RNase protection using probes 
specific for c-fos and ~-globin transcripts. The c-fos 
probe hybridizes to transcripts of the transfected c-fos- 
Figure 1. {A) Sequence of the c-los SRE. The wild-type se- 
quence shown corresponds t  positions -315 to -294 in the 
mouse c-fos gene. The arrows indicate the limits of the dyad 
symmetry; the A-T base pairs on either side of the center of 
symmetry are not marked. The asterisks mark the guanosine 
residues that interfere with factor binding in vitro, when meth- 
ylated by dimethylsulfate {Gilman et al. 1986~ Treisman 1986). 
These are also the base pairs mutated in the pm12 mutant. The 
nucleotides shown also comprise the limits of the oligonucleo- 
tides used in these experiments. (Forthe complete sequences of 
the oligonucleotides used, e Materials and methods.) (B) c-los 
hybridization probe used in the RNase protection assays. The 
top line represents he transcription template. The rig t-facing 
arrow indicates the start site for SP6 RNA polymerase. The 
left-facing arrow below the line indicates the initiation site for 
c-los transcripts. {H3) The HindIII site used to linearize the 
template for transcription. The second line represents the RNA 
probe transcribed from this template, and th  bottom two lines 
represent the fragments ofthe probe protected by transcripts of 
the transfected c-los-CAT genes and the endogenous c-los 
gene, respectively. The stippled boxes represent c-fos quence: 
heavy stippling indicates transcribed sequence; light stippling 
is 5'-flanking sequence. The thick line represents linker s - 
quences present i  both the probe and the c-los-CAT tran- 
scripts but not in endogenous c-los mRNA. 
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comparison of the transfected c-fos signals within a 
panel in each figure. Between sets that received ifferent 
plasmids, however, transfection efficiencies were not 
always equivalent, so direct comparisons of signals from 
the transfected c-fos gene in different panels may not be 
made. 
Figure 3 shows the results of an experiment in which 
wild-type and mutant  c-fos fusion genes were trans- 
fected into BALB/c 3T3 cells and induced by treatment 
with the agents listed above. The fusion gene carrying 
wild-type c-los sequences was strongly induced by all 
stimuli (left panel), showing that it carries sequences 
sufficient for response to each activator. In contrast, the 
gene carrying the pml2  mutations in the SRE showed 
sharply reduced response to serum, c-sis, and PMA, al- 
though it still responded to activators of the cyclic AMP 
(cAMP) system (right panel, compare upper bands to 
control lane, NA). The endogenous c-fos genes in these 
Figure 2. The pm12 mutations reduce factor binding in vitro. 
Mobility-shift assays were carried out using a 5'-end-labeled re- 
striction fragment carrying mouse c-los DNA from -356 to 
-274 (20,000 cpm, 0.4 ng) and crude nuclear extract from 
WEHI 231 cells {5 txg}. (Lane 1) No added extract; (lane 2) stan- 
dard binding reaction with no competitor restriction fragments 
added; (lanes 3-6) reactions contained the indicated molar ex- 
cess (3-fold, 10-fold, etc.) of a purified restriction fragment carry 
wild-type c-fos sequences from -356 to + 109; (lanes 7-10) re- 
actions contained the indicated molar excess of a purified re- 
striction fragment carrying c-fos sequences from -356 to + 109 
with the pml2 mutations. 
CAT fusion genes and to endogenous c-los mRNA, 
yielding two protected fragments in all assays (Fig. 1B). 
The largest fragment (128 nucleotides, T in Figs. 3-6} is 
protected by correctly initiated transcripts of the trans- 
fected c-los gene. The next smaller fragment (110 nu- 
cleotides, E) is protected by correctly initiated tran- 
scripts of the endogenous c-los gene of the host cells. 
This signal provides a control for the efficacy of induc- 
tion for each dish of cells. The smallest fragment (95 nu- 
cleotides, marked a) derives from correctly initiated 
transcripts of the cotransfected a-globin gene. This 
signal provides a measure of the transfection efficiency 
for each dish. Because all dishes transfected with the 
same plasmids received aliquots of a single large trans- 
fection precipitate, transfection efficiencies were gener- 
ally equivalent within that set of dishes, allowing direct 
Figure 3. The pml2 mutations reduce the response of trans- 
fected c-los-CAT fusion genes to whole serum, c-sis, and PMA, 
but not to IBMX and forskolin. BALB/c 3T3 cells were trans- 
fected with the indicated plasmids, A-356 wt and A-356 pml2, 
as described in Materials and methods. Following 48 hr of incu- 
bation in medium containing 0.5% calf serum, cells were ex- 
posed for 45 rain to the agents hown at the top of each lane. 
RNA was isolated and assayed by RNase protection as de- 
scribed in the text. {NA) No addition, cells treated with serum- 
free medium; (CS) cells treated with medium containing 10% 
calf serum; (SIS) cells treated with 40 ng/ml c-sis protein in 
serum-free medium; (PMA) cells treated with 50 ng/ml (-80 
nM) PMA; (IF) cells treated with 0.5 mM IBMX and 10 ~M fors- 
kolin in serum-free medium. (T) The position of c-los probe 
fragments protected by transcripts of the transfected genes; (E) 
fragments of the c-los probe protected by endogenous c-los 
transcripts; (a) fragments protected by transcripts of the a- 
globin control plasmid. Note that the relative intensities of the 
a-globin bands show that the dishes that received -356 pml2 
DNA were transfected with lower efficiency than the dishes 
that received the wild-type plasmid. This difference in transfec- 
tion efficiency accounts for much of the absolute difference in 
signal intensity for the transfected genes. 
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cells were induced normally, showing that the reduction 
in response of the transfected genes was due to the intro- 
duced mutations, not to the absence of an inducing 
signal. The residual response of the pml2 mutant to 
c-sis is reproducibly seen, although the magnitude is 
highly variable. That the pml2 mutations do affect c-sis 
response may be seen by comparing the c-sis signal to 
that obtained with IBMX and forskolin. Induction by 
c-sis is stronger than IBMX and forskolin, with the wild- 
type gene, whereas induction by c-sis is weaker with the 
mutant. This experiment, ogether with the binding 
assays shown in Figure 2, confirms that an intact pro- 
tein-binding site is required for the serum response 
(Greenberg et al. 1987; Treisman 1987). Furthermore, it
shows that the SRE is also required for c-fos induction 
by PMA, presumably through activation of pkC and for 
full response to c-sis protein. Third, this experiment 
suggests that c-fos induction via the cAMP second mes- 
senger system does not require an intact SRE and that 
sequences ufficient for this response lie elsewhere in 
the gene. 
The previous experiment showed that c-fos activation 
by serum, c-sis, and PMA requires the SRE. PMA is 
thought to act largely through activation of pkC, but 
serum growth factors act through other pathways be- 
sides pkC. To determine whether the SRE was required 
for response to pkC-independent signals, transfected 
c-fos genes were induced in cells depleted of pkC ac- 
tivity. Cultures of cells were transfected with either the 
wild-type or the pml2 c-fos-CAT fusion genes. Imme- 
diately following transfection, cells were treated for 48 
hr with medium containing 0.5% calf serum and 100 
ng/ml phorbol dibutyrate (PDBu). Control cultures re- 
ceived the solvent dimethylsulfoxide (DMSO). Chronic 
treatment with active phorbol esters esults in down- 
regulation of pkC and the disappearance of assayable 
pkC activity in extracts of the treated cells (Collins and 
Rozengurt 1984; Rodriguez-Pena nd Rozengurt 1984). 
Therefore, this protocol establishes a temporary state in 
which cells are deficient in phorbol ester-activatable 
pkC, and any residual growth factor-induced response 
is presumably due to signaling pathways independent of
such enzymes. Although endogenous c-fos expression in 
control cultures was induced by all stimuli (Fig. 4, left 
panell, the PDBu-treated cultures were refractory to in- 
duction by PMA (Fig. 4, middle and right panels), sug- 
gesting that these cells lacked PMA-activatable pkC. In-
duction by serum and c-sis was partially reduced, sug- 
gesting a partial reliance on pkC. Induction by IBMX and 
forskolin was largely unaffected, suggesting that this 
pathway is pkC independent. Under these conditions, 
the transfected wild-type fusion gene still responded to 
serum and c-sis (middle panel), though not as strongly as 
in the control cells. Therefore, this gene must carry se- 
quences sufficient for response to pkC-independent 
signals. Mutations in the SRE abolished response to 
serum and c-sis in the pkC-deficient cells (Fig. 4, right 
panel). Induction by IBMX and forskolin was again unaf- 
fected by the SRE mutations. Thus, this experiment es- 
tablishes that in addition to the pkC pathway, the SRE is 
required for response to one or more pkC-independent 
pathways triggered by serum and c-sis. 
An SRE oligonucleotide confers responsiveness to both 
pk C-depen den t an d -in depen den t sign aling pa th ways 
Short oligonucleotides carrying the SRE restore serum 
inducibility to deleted c-fos and heterologous promoters 
(Treisman 1986, 1987; Greenberg et al. 1987; Mohun et 
al. 1987). To determine whether the SRE alone is suffi- 
cient for response to different signaling pathways, syn- 
thetic oligonucleotides ncoding 22 bp of wild-type SRE 
sequence or the corresponding sequence carrying the 
pml2 mutations (see Fig. 1A) were inserted just up- 
stream of a deleted c-fos-CAT fusion gene. The deleted 
gene carries c-fos sequences through -151 and includes 
several basal promoter elements (Gilman et al. 1986). 
Figure 5 shows that the parental -151 construct re- 
sponds weakly, if at all, to serum, c-sis, and PMA, al- 
though it does respond to IBMX and forskolin (left 
panel). Insertion of a single copy of the wild-type SRE 
oligonucleotide immediately upstream restores response 
Figure 4. The pml2 mutations reduce the response 
of transfected c-los-CAT fusion genes to pkC-inde- 
pendent signals. BALB/c 3T3 cells were transfected 
and treated for~48 hr with medium containing 0.5% 
calf serum and 0.1% DMSO (left panel) or medium 
containing 0.5% calf serum and 100 ng/ml PDBu 
(middle and right panels). (NA) no addition; (CS) 
10% calf serum; (SIS) 40 ng/ml c-sis protein; (PMA) 
50 ng/ml PMA; (IFI 0.5 mM IBMX and 10 ~M fors- 
kolin. (For details, see Materials and methods and
the legend to Fig. 3)
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to serum, c-sis, and PMA with little effect on induction 
of IBMX and forskolin (middle panel). Insertion of a mu- 
tant SRE oligonucleotide in the same position has no ef- 
fect on any response (right panel). Therefore, a single 
copy of the SRE is sufficient for response to serum, c-sis, 
and PMA, at least in the presence of the downstream 
basal elements. A single copy of the mutant SRE is inac- 
tive. Further, these data show that sequences sufficient 
for response to the putative cAMP pathway lie down- 
stream of - 151. 
The same constructs carrying the wild-type and pm 12 
SRE oligonucleotides were transfected into cells, and the 
cells were treated for 48 hr with PDBu, as described pre- 
viously. Figure 6 shows that genes carrying a mutant 
SRE oligonucleotide responded only to IBMX and fors- 
kolin (left panel). Genes with a wild-type oligonucleo- 
tide were also induced by serum and c-sis (right panel). 
Thus, the SRE is also sufficient for response to growth 
factor-activated pkC-independent pathways operating 
in these cells. Therefore, the SRE is necessary and suffi- 
cient for the response of c-fos to at least two distinct 
intracellular signaling pathways, one dependent on pkC, 
and one or more pkC-independent pathways. The SRE 
does not appear to play a direct role in the response to 
cyclic nucleot ide-mediated signals. 
Discuss ion  
The c-los proto-oncogene is a highly inducible gene that 
is sensitively coupled to external signals. Transcription 
of c-fos is activated in response to signals that are di- 
verse in both their chemical structures and biological ac- 
tivities. Previous work has shown that a single sequence 
element, the SRE, is essential for the response of c-los to 
whole serum (Treisman 1985, 1986; Gi lman et al. 1986; 
Greenberg et al. 1987). But serum is a complex mixture 
of biologically active agents, with cooperating and antag- 
onistic activities on cells. Furthermore, constituents of 
serum activate several distinct intracellular signaling 
pathways. The goal of the studies described here was to 
determine which of these pathways act on the c-fos gene 
through the SRE and which require other sequences. 
Figure 5. A wild-type but not a pml2 SRE oligonu- 
cleotide restores response to serum, c-sis, and PMA. 
BALB/c 3T3 cells were transfected with a c-fos- 
CAT fusion gene carrying c-fos sequences through 
-151 (left panel), the same construct carrying a 
single copy of a wild-type SRE oligonucleotide 
(middle panel), or the same construct carrying a 
pml2 SRE oligonucleotide (right panel). (For the se- 
quences of these oligonucleotides, see the legend to 
Figure 1 and Materials and methods.) (NA) No addi- 
tion; {CS) 10% calf serum; (SIS) 40 ng/ml c-sis pro- 
tein; (PMA) 50 ng/ml PMA; (IF) 0.5 mM IBMX and 
10 I~M forskolin. 
The results show that he c-fos SRE is the target of at 
least two intracellular signaling pathways, whereas a 
third pathway induces c-fos expression independently of 
the SRE. 
Fresh serum and several purified growth factors stimu- 
late inositol phospholipid turnover in sensitive cells (for 
review, see Michell and Putney 1987). One product of 
this reaction is diacylglycerol, which activates a family 
of closely related protein kinases known as pkC (Nishi- 
zuka 1986). This intracellular signaling pathway appears 
to communicate with the c-fos gene primarily through 
Figure 6. A wild-type but not a pml2 SRE oligonucleotide r - 
stores response to pkC-independent signals. BALB/c 3T3 cells 
were transfected with c-los-CAT fusion genes carrying c-los 
sequences through -151 plus a pm12 SRE oligonucleotide (l ft 
panel) or a wild-type SRE oligonucleotide (right panel). Cells 
were treated with PDBu, as described in the legend to Figure 4 
and in Materials and methods. (NA) No addition; (CS) 10% calf 
serum; (SIS) 40 ng/ml c-sis protein; (PMA) 50 ng/ml PMA; {IF) 
0.5 mM IBMX and 10 ~M forskolin. 
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the SRE. Point mutations in the SRE almost completely 
eliminate c-fos induction by the potent pkC activator 
PMA. The small remaining induction seen with a mu- 
tant SRE may be due to PMA-induced modification of 
other cellular transcription factors. A growing group of 
sequence lements have been implicated in regulation of 
gene expression by activators of pkC. These include se- 
quences in the SV40 enhancer (Imbra and Karin 1986; 
Angel et al. 1987; Chiu et al. 1987; Imagawa et al. 1987; 
Lee et al. 1987a), the HIV LTR (Kaufman et al. 1987; 
Nabel and Baltimore 1987; Siekevitz et al. 1987; Tong- 
Starksen et al. 1987), and several cellular genes (Comb et 
al. 1986; Elsholtz et al. 1986; Angel et al. 1987; Imagawa 
et al. 1987; Lee et al. 1987a). Related sequences arefound 
in the c-fos gene. In particular, the c-fos gene carries a 
consensus binding site for the PMA-inducible transcrip- 
tion factor AP-1 (Angel et al. 1987; Lee et al. 1987a, 
1987b), and Piette and Yaniv (1987) have shown that this 
site binds a cellular factor. But the data shown here and 
by others (Fisch et al. 1987; 8tumpo et al. 1988) suggest 
that this site is not important for c-fos induction by 
PMA. 
These data also show that serum and c-sis transmit 
signals to the c-fos gene that are independent of phorbol 
ester-activatable pkC, as shown previously by others 
(Stumpo and Blackshear 1986; Blackshear et al. 1987; 
Bravo et al. 1987) and show further that these signals act 
through the SRE. The nature of these signals is unclear. 
pkC is now known to comprise a large family of en- 
zymes, some of which may not be depleted by phorbol 
ester treatment (Coussens et al. 1986; Knopf et al. 1986; 
Makowske et al. 1986; Ono et al. 1986; Parker et al. 
1986; Housey et al. 1987). Therefore, involvement of 
some form of pkC in c-fos induction after chronic 
phorbol ester treatment cannot be ruled out formally. 
Another candidate signal that could operate under these 
conditions is the increase in cytoplasmic calcium levels 
that is also a consequence of inositol phospholipid turn- 
over. Indeed, in many cell types, agents that act to in- 
crease intracellular calcium levels induce c-fos expres- 
sion efficiently (Bravo et al. 1985, 1987; Milbrandt 1986; 
Moore et al. 1986; Morgan and Curran 1986). However, 
in the cells used here, calcium ionophores fail to induce 
c-los expression significantly (data not shown), an obser- 
vation also reported for another clone of BALB/c 3T3 
cells (Ran et al. 1986). Therefore, the identity of the 
growth factor-induced signaling pathways that act on 
c-fos under these conditions is not known. 
Another intracellular signal that induces c-fos expres- 
sion in some cells is accumulation of intracellular 
cAMP. Agents that increase intracellular cAMP are re- 
ported to induce transient c-fos expression in the PC-12 
pheochromocytoma cell line (Greenberg et al. 1985; 
Kruijer et al. 1985) but not in two fibroblast lines (Ran et 
al. 1986; Bravo et al. 1987). In macrophages, cAMP in- 
duces c-fos but with markedly different kinetics (Bravo 
et al. 1987). In the fibroblast line used in the present ex- 
periments, induction by cAMP is rapid and transient, al- 
though relatively weak and with slightly slower kinetics 
than induction by serum (L.A. Berkowitz and M.Z. 
Gilman, unpubl.). It has not yet been directly shown 
that treatment of these cells with IBMX and forskolin 
significantly augments cellular cAMP levels. However, 
this pathway has sequence requirements distinct from 
the other two pathways examined. It is independent of
the SRE and requires, at least in part, c-fos sequences 
between -151 and +109. It has been noted that the 
c-fos gene contains equences located at -290 and -65  
with similarity to cAMP regulatory elements in other 
genes (Comb et al. 1986; Montminy et al. 1986). The 
c-fos gene also contains several matches to the con- 
sensus binding site for transcription factor AP-2 (Ima- 
gawa et al. 1987; Mitchell et al. 1987), and polymerized 
binding sites for this factor are cAMP responsive in vivo 
(Imagawa et al. 1987). 
A reproducible observation in these experiments was 
the slight induction of the pml2 mutants with c-sis (see 
Figs. 3 and 4). The variable nature of the residual induc- 
tion obtained with the mutant suggests that this con- 
struct may be responding to a signaling pathway that is 
variably active in these cells, depending on the precise 
growth conditions (Ran et al. 1986; Rollins et al. 1987). 
This observation raises the possibility that other se- 
quences in the c-fos gene are capable of specifically re- 
sponding to c-sis or PDGF. One candidate is a sequence 
25 bp upstream of the SRE that binds a cellular factor 
specifically induced by conditioned medium from v-sis- 
transformed cells (Hayes et al. 1987). However, induc- 
tion by c-sis in both the presence and absence of pkC is 
strongly affected by SRE mutations (Figs. 3 and 4), sug- 
gesting a major role for the SRE, and induction by c-sis 
also occurs in the absence of this upstream sequence 
(Figs. 5 and 6). A second possible explanation for induc- 
tion of the pm12 mutant by c-sis is that this induction is 
due to effects on intracellular cAMP concentrations elic- 
ited by PDGF (Rozengurt et al. 1983). Arguing against 
this model is the observation that c-fos constructs con- 
taining sequences through - 151 and lacking an SRE fail 
to respond to c-sis, although they do respond to IBMX 
and forskolin (Figs. 5 and 6). Additional mutagenesis 
studies will be necessary to distinguish between these 
alternatives. 
How are the distinct signals that act through the SRE 
coupled to c-fos transcription? One possibility is that 
these pathways converge, each acting through the same 
SRE-binding protein. An alternate possibility is that 
each pathway communicates with a unique or dedicated 
SRE-binding protein. Only one SRE-binding activity is 
detected in nuclear extracts using the mobility-shift 
assay, but the presence of this activity in extracts does 
not correlate perfectly with the transcriptional ctivity 
of the c-fos gene. For example, the activity is present in 
many extracts of cells not transcribing c-fos (Gilman et 
al. 1986; Prywes and Roeder 1986; Treisman 1986; Fisch 
et al. 1987; Greenberg et al. 1987; Stumpo et al. 1988). It 
is reported absent in cells in which c-fos transcription 
has been induced with PMA or calcium ionophore 
(Prywes and Roeder 1986). Nevertheless, the results pre- 
sented here suggest hat cellular proteins with the 
binding specificity of this nuclear factor are indeed re- 
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quired for response to PMA and to pkC- independent  
signals. Therefore, if these pathways all act through this 
single factor, its act ivity does not appear to be str ict ly 
regulated through control of its DNA-binding activity, 
in contrast to factors that bind to other PMA-inducible 
e lements (Sen and Balt imore 1986; Angel et al. 1987; 
Franza et al. 1987; Dinter  et al. 1987; Nabel and Balti- 
more 1987; Wu et al. 1988). Alternatively, there may be 
addit ional SRE-binding proteins not detected by the mo- 
bi l i ty-shift  assay. With the recent purif ication of HeLa 
cell proteins that bind to the SRE (Prywes and Roeder 
1987; Schroter et al. 1987; Tre isman 1987) direct data 
bearing on the roles cellular proteins play in c-los induc- 
t ion may soon be available. 
Mater ia ls  and methods  
Materials 
PMA, PDBu, forskolin, and IBMX were obtained from Sigma. 
PMA stocks were made up at 100 ~zg/ml (162 ~M) in DMSO. 
Forskolin stocks were 10 mM in ethanol. IBMX stocks were 0.5 
M in DMSO. Final concentrations of DMSO and ethanol applied 
to cells were no more than 0.1% (vol/vol). At these concentra- 
tions, the solvents had no effect on c-fos expression, c-sis pro- 
tein, B-chain homodimers of PDGF, was purchased from 
Amgen Biologicals. 
Plasmids and mutagenesis 
Most of the mouse c-fos-CAT fusion plasmids used in these 
studies were described previously (Gilman et al. 1986). For mu- 
tagenesis, a HindIII-EcoRI fragment from the &-356 c-fos-CAT 
fusion was transferred to M13 mpl 1. Mutagenesis was carried 
out with the two-primer method described by Zoller and Smith 
(1984) and was done in two steps. In the first step, the 3' pair of 
G-C base pairs was mutagenized using the oligonucleotide 5'- 
CGCAGATGTGGTAATATGGACATCCTG-3'. The resulting 
mutant was mutagenized further using the oligonucleotide 5'- 
TAATATCCACATCCTGTGTAAAGGAGG-3'. Mutant phage 
were identified by plaque hybridization using the mutagenic 
oligonucleotides, plaque purified, and sequenced. Mutant c-los- 
CAT fragments were recloned into plasmid vectors. 
SRE oligonucleotides (5'-GTCGGATGTCCATATTAGGA- 
CATCT-3' and 5'-GACAGATGTCCTAATATGGACATCC-3' 
for wild-type; 5'-GTCGGATGTGGATATTACCACATCT-3' 
and 5'-GACAGATCTGGTAATATCCACATCC-3' for prnl2) 
were phosphorylated, annealed, ligated briefly, and treated with 
the Klenow fragment of DNA polymerase to blunt overhanging 
ends. These mixtures of tandemty repeated oligonucleotides 
were cloned into the HincII site of pUCII9 and screened by 
DNA sequence analysis. Restriction fragments carrying the 
cloned oligonucleotides were recovered as HindIII-SalI frag- 
ments and inserted between the HindlII and SalI sites immedi- 
ately upstream of the c-los promoter sequences in c-fos-CAT 
A-151 (Gilman et al. 1986). 
All plasmid constructions were verified by DNA sequence 
analysis. Plasmids for transfections were purified twice in 
CsC1/EtBr gradients. DNA concentrations were determined by 
UV absorbance and confirmed by agarose gel electrophoresis. 
Mobility-shift assay 
The assay procedures, extracts, and probes were described in 
detail in Gilman et al. (1986). Competitor fragments were pre- 
pared by digestion of the A-356wt and A-356pm12 plasmids 
with HindIII and BamHI, and purification by polyacrylamide 
gel electrophoresis of the 484-bp fragment carrying c-fos se- 
quences -356 to + 109. The concentrations of the purified 
fragments were estimated by comparison to standards on poly- 
acrylamide gels. 
Transfections 
BALB/c 3T3 cells were carried in Dulbecco's modified essential 
medium (DMEM) containing 10% calf serum and antibiotics. 
Cells were split 1 : 6 to 1 : 12 for 12-24 hr prior to transfection, 
so that cultures were approximately 20-30% confluent at 
transfection. Cells were fed with 9 ml warm fresh medium 1 hr 
before transfection. Cells were transfected using a calcium 
phosphate coprecipitation procedure, c-fos-CAT DNA (52 ~g) 
and ~rSVHPe~2 (Treisman et al. 1983) DNA (10.4 ~g) were di- 
luted to 2.6 ml of 10 mM Tris (pH 7.5), 1 mM EDTA, and 250 
mN CaCIz. This solution was added with gentle vortexing to 
2.6 ml of 50 mM HEPES (pH 7.12), 280 mN NaC1, and 1.5 mlvi 
Na2HPO 4. The precipitate was allowed to stand for 2 min and 
then distributed in 1-ml aliquots onto five dishes. Each plate of 
cells received 10 txg of c-los-CAT DNA and 2 ~zg of the internal 
control plasmid -rrSVHPa2. All plates receiving the same con- 
structions received aliquots of the same large precipitate, mini- 
mizing plate-to-plate variability among these dishes. Cells were 
incubated in the precipitates for 16-18 hr at 37~ The mono- 
layers were washed three times with warm phosphate-buffered 
saline (PBS) and refed with 10 ml of DMEM containing 0.5% 
calf serum. Incubation continued for 48 hr at 37~ The me- 
dium was removed, the cells were washed once with warm PBS, 
and inducers were added in 3-ml serum-free DMEM. The con- 
trol cells were handled identically and incubated in 3-ml 
serum-free DMEM alone. After 45 min at 37~ the medium 
was removed, and cells were placed on ice and flooded with 
ice-cold PBS. The monolayers were washed a total of three 
times with ice-cold PBS prior to RNA extraction. 
pkC down-regulation experiments were carried out identi- 
cally, except hat after transfection, cells received DMEM con- 
taining 0.5% calf serum and 100 ng/ml PDBu. Control cultures 
received the same medium with an equal amount of DMSO 
(0.1%1. 
RNA analysis 
Total cytoplasmic RNA was prepared essentially as described 
previously (Gilman et al. 1988) with two modifications. The 
cytoplasmic extract was treated with 125 izg/ml proteinase K
for 15 min at 37~ prior to organic extraction. Second, the pre- 
cipitated cytoplasmic RNA was treated with DNase I as 
follows. The RNA pellets were redissolved in 50 ixl RNase-free 
TE buffer. Following the addition of 50 Ixl of a solution con- 
taining 10 mM Tris [pH 8), 1 mM EDTA, 20 mM MgC12, 2 mM 
dithiothreitol, 500 U/ml RNasin (Promega), and 200 U/ml 
RNase-free DNase I (Worthington DPRF), the RNA was incu- 
bated for 15 min at 37~ DNase digestion was stopped by the 
addition of 25 p.l of a solution containing 50 nan EDTA, 1% 
(wt/vol) SDS, and 1.5 M sodium acetate. RNA was finally recov- 
ered by extraction with phenol/chloroform/isoamyl alcohol 
(25 : 24 : 1) and chloroform/isoamyl alcohol I24 : 1), followed 
by ethanol precipitation. 
RNase protection assays were carried out as outlined in 
Melton et al. (1984), with a number of modifications. Probes 
were prepared with either SP6 or T3 RNA polymerases using 
100 btCi e~-[azP]CTP and were gel purified before use. Hybridiza- 
tions contained 10 ~g total cytoplasmic RNA, 500,000 dpm 
c-fos probe, and 200,000 dpm of e~-globin probe in a total 
volume of 30 ~xl. Hybridization mixtures were incubated for 5 
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min at 85~ and then overnight (8-16 hr) at 45~ RNase diges- 
tions were carried out for 60 min at room temperature and con- 
tained only RNase T1 (2 ~g/ml). Electrophoresis was on 8% 
(wt/vol) polyacrylamide, 50% (wt/vol) urea sequencing gels. 
The c-los probe was prepared from a plasmid carrying c-fos 
sequences from - 56 to + 109 [nucleotides 79-243 in Van Be- 
veren et al. (1983)]. The plasmid was prepared by inserting a
HindIII-BamHI fragment from c-fos-CAT fusion plasmid A-56 
(Gilman et al. 1986) into HindIII-BamHI-digested pSP65. 
Plasmid DNA was linearized with HindIII and transcribed with 
SP6 RNA polymerase {New England Biolabs) to yield a 225-nu- 
cleotide probe containing c-los sequences found in transcripts 
of both the endogenous c-fos gene and the transfected genes and 
flanking linker sequences present only in the transfected gene 
transcripts ( ee Fig. 1B). The c~-globin probe was prepared from a 
plasmid consisting of a 110 bp BssHII fragment of the human 
~-globin gene (-15 to +95) cloned into the HindIII site of 
pBSM13 + (Stratagene). The probe was prepared by transcrip- 
tion of XbaI-digested template with T3 RNA polymerase (Stra- 
tagene). 
In the figures, the major protected bands correspond to RNase 
T1 cleavage of the probes at the guanosine residues nearest the 
hybrid boundaries. Therefore, they do not indicate the precise 
5'-end of the transcripts. Weak bands running above the major 
cleavage products represent incomplete RNase T1 digestion 
products that are cleaved at the next guanosine residue either 
upstream or downstream of the hybrid. 
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